STARPHARMA HLDG.SP.ADR/10 (PQ6A) — Net Asset Quality Index
STARPHARMA HLDG.SP.ADR/10 (PQ6A) has a Net Asset Quality Index of 74.7% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €25.42 Million minus total liabilities of €6.42 Million yields net assets of €19.00 Million. A higher index indicates a stronger, lower-leverage balance sheet. See defensive interval ratio of STARPHARMA HLDG.SP.ADR/10 to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
STARPHARMA HLDG.SP.ADR/10 Net Asset Quality Index Over Time (2022–2025)
This chart shows how STARPHARMA HLDG.SP.ADR/10's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of June 2025, the index stands at 74.7%, representing net assets of €19.00 Million against total assets of €25.42 Million EUR. Also explore STARPHARMA HLDG.SP.ADR/10 assets under control for the complete picture of this company's asset base.
Annual Net Asset Quality Index for STARPHARMA HLDG.SP.ADR/10 (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for STARPHARMA HLDG.SP.ADR/10 from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is STARPHARMA HLDG.SP.ADR/10 worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.7% | €19.00 Million | €25.42 Million | €6.42 Million | ▼ -1.6 pp |
| 2024 | 76.4% | €28.12 Million | €36.81 Million | €8.70 Million | ▲ +9.5 pp |
| 2023 | 66.8% | €34.81 Million | €52.09 Million | €17.27 Million | ▼ -6.3 pp |
| 2022 | 73.1% | €48.39 Million | €66.17 Million | €17.78 Million | — |